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PAPILLOMATA have been observed in mice treated with croton oil only (Beren-
blumi, 1941; Salaman and Gwynn, 1951). The latter authors observed one tumour
which they considered to be malignant. Recently, malignant skin tumours
following this treatment have been reported by Roe and Salaman (1955) and
Boutwell, Rusch and Bosch (1955).
The purpose of the present experim'ent was to determine whether benign or
malignant tumours would appear during or after a limited course of treatment
with croton oil such as had been used in previous experim'ents (Rusch and Kline,
1946; Berenblum and Shubik, 1947a,, 1947b, 1949; Salaman and Gwynn, 1951 ;
Salaman and Roe, 1953; Berenblum and Haran, 1955), or as a result of much
more prolonged treatment with croton oil.
The first group of 20 mice included in the present communication have been
referred to previously (Roe and Salaman, 1955). These mice were given 72 weekly
applications of 0-3 ml. 0-5 per cent croton oil in acetone to the skin of the back,
and at the-time of the previous report had developed 3 malignant tumours of the
skin (at 55, 67, and 72 weeks, respectively). Further malignant tumours have
subsequently arisen in the mice which were still alive at that time: these are
described below.
In the same report the incidence' of pulmonary tumours in mice treated with
croton oil only was discussed (Roe and Salaman, 1955, p. 196). Fuirther data on the
incidence of these tumours is now given.
MATERIALS AND METHODS
C1roton oil.-Two batches of croton oil were used, the first (Batch I) has beeni
used in experiments in this laboratory .for several years (Salanian and Gwynn,
1951; Salaman, 1952; Salaman and Roe, 1953; Roe and Salaman, 1954; Roe,
1955).
The second (Batch II) was obtained in 1954 from the same source as Batch I,
namely Messrs. Stafford, Allen and Sons, Ltd., 20, WharfRoad, N.1. Both batches
were prepared from the seeds of Croton tiglium by simple expression. Batch II
has been found to be slightly more irritant to the skin than Batch I. The concen-
tration of croton oil applied to different groups of mice, which in some cases
formed control groups for other experiments, was influenced by the sensitivity of
mice to the irritant-,action of the batch of oil used.
Further details ofmaterials and methods are fully described in the first paper of
this series (Roe, 1956; p. 62).DEVELOPMENT OF TUMOURS OF MOUSE SKIN
EXPERIMENTAL
Six groups of 20 mice were used in the experiment. They were treated with
croton oil as follows (see also Table I):
Group 1 were given 72 weekly applications of 0-5 per cent Batch I oil, and
observed until the mice were all dead.
Group 2 were given 18 weekly applications of 05 per cent Batch I oil, and killed
shortly after the end of treatment, in order to observe the incidence of pulmonary
adenomata at that time.
Group 3 were given 18 weekly applications of 05 per cent Batch I oil, and there-
after kept under observation without treatment. It is now 50 weeks since treatment
was begun (i.e. 32 weeks from the end of treatment) and 18 mice are still alive.
Group 4 received successively, 1 application of 0-17 per cent, 2 applications
of0 I per cent, and 15 applications of 0X 17 per cent Batch II oil, at weekly intervals.
The concentration ofthe second and third applications was reduced to 0.1 per cent
because the first application of 0 17 per cent caused ulceration followed by
scab-formation in some of the mice. The fourth and subsequent applications
at a concentration of 0-17 per cent were, however, well tolerated. These mice
have also been kept under observation since the end of treatment. It is now 42
weeks since the beginning of treatment (i.e. 24 weeks from the final application
of croton oil) and 14 mice are still alive.
Grroups 5 and 6 are still under prolonged treatment with weekly applications
of BatchII oil: Group 5 at a concentration of 0-17 per cent, and Group 6 at 0.5
per cent. Treatment is at present inits 43rd week, and there are 8 survivors in
Group 5 and 13 in Group 6.
TABLEI.-The Incidence of Papillomata following Treatment with Croton Oil Alone.
Incidence of Incidence of
papillomata 18 weeks after papillomata 42 weeks after
Weekly treatment the beginning of treatment. the beginning of treatment.
with croton oil. -A ' I "--- Number Number Concen- Number of Total of Total
Number Batch tration of Number tumour- number Number tumonir- number
of of oil in appli- of bearing of of bearing of
Group. mice. used.* acetone. cations. survivors. mice. tumours. survivors. niice. tumours.
1 20
I 0.5% 72
. 20 1 3 . 19 8 18
20 I 0 500 18 17 1 3
3 20
. I 0.5% 18 20 1 1 . 19 0 0
4 .20. II 0-17%j 18 19 4 4 . 14 1 1
5 .20. II 0.17% 42t. 17 0 0. 8 5 12
6
. 20
. II 0 5% 42t 19 4 4 . 13 6 15
* Seep. 72.
These mice are still under treatnment. $
2nd and 3rd weekly applications were 0-1 per cent only (see text, this page).
RESULTS
(a) The incidence of papillomata of the 8kin
The incidence of papillomata in each group one week after the 18th application
of croton oil is shown in TableI. In all except one of the six groups (Group 5)
papillomata were present at this time; but in no group was the incidence as high
as
1 tumour per 4 surviving mice.
Mice of Groups 3 and 4, which are still under observation, 32 weeks and 24
weeks, respectively, after the end of a course of 18 applications of croton oil, have
developed no new tumours since the end of treatment. Four out of 5 of the
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papillomata which were present in these mice at the end of treatment have disap-
peared.
Mice of Group 1 steadily accumulated papillomata until croton oil treatlment
came to an end at the 72nd week. By that time there were 10 survivors, of which 5
bore papillomata. The numbers ofpapillomata borne by the individual mice were
13, 8, 7, 6 and 3, respectively. All papillomata arose on the treated areas of skin.
During the 8 weeks immediately following the end of croton oil treatment 7 more
papillomata appeared. Four of these new tumours arose in a mouse which had
previously had none. After the 80th week of the experiment no more tumours
appeared, in fact several disappeared.
Numberofweeklyapplications ofcroton oil
FIG. 3.-Development of papillomata in mice during weekly croton oil treatment (Group 1).
Mean number of papillomata per sufviving mouse is plotted against time during the period
ofweekly applications ofcroton oil. Numbers ofsurvivors ofthe original 20 mice are shown
in brackets.
Fig. 1 and 2 depict 2 mice ofGroup 1 with papillomata. Fig. 3 shows the mean
numbers of papillomata per surviving mouse throughout the period of croton oil
treatment.
Mice ofGroups 5 and 6 are still under treatment with croton oil. At the time of
writing they have received 42 weekly applications. Papillomata are steadily
accumulating in both groups, and their incidence curve has so far closely followed
that previously observed in Group 1 (Fig. 4).
(b) The incidence of malignant tumours of the skin
Malignant tumours of the skin appeared on the backs of 6 mice of Group 1.
One mouse bore 2 malignant tumours. The malignant character of all these
tumours was confirmed histologically, using the criterion of penetration of the
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panniculus carnosus (Roe, 1956; p. 66); all were carcinomata. Metastases were
present in the regional lymph glands of 2 mice. The first carcinoma appeared
during the 55th week of treatment, and the mean interval between the beginning
of treatment and appearance of malignant tumours was 78S1 weeks (S.D.= ± 7-1
weeks).
Fig. 5 shows the back of the mouse from Group 1 which bore two malignant
tumours, and Fig. 6 to 9 show the histological appearances ofthese two tumours.
No malignant tumours have so far appeared in Groups 3 to 6, which are still
under observation.
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Numberofweeklyapplications ofcroton oil
Fio. 4.-Development of papillomata in mice treated with different batches of croton oil.
x - - x Group 1: Weekly applications of 0 3 ml. 0 5 per cent Batch I croton oir
in acetone.
O .0 Group 5: Weekly applications of 03 ml. 0 17 per cent Batch II croton
oil in acetone.
* * Group 6: Weekly applications of 0* 3 ml. 0-5 per cent Batch II croton oil
in acetone.
Numbers of survivors are shown in brackets.
The question arises whether the tumours which appeared in these mice have
been due to accidental contamination with carcinogenic substances, which were
being used in the laboratory at the time. In spite of careful precautions this
possibility cannot be excluded. However there are some indications from the
results that contamination is not likely to have contributed to the tumour produc-
tion observed. Forinstance, mice of Group 1 were housed during croton oil treat-
ment in two separate cages, each of which contained 10 mice. The incidence and
rate of development of papillomata was very similar in the two cages (Fig. 10)..F. J. C. ROE
Three malignant tumours occurred in one cage after an average latent interval of
75-3 weeks, and 4 in the other after 74*0 weeks. If accidental contamination with
a powerful carcinogen, such as DMBA, contributed to the induction of benign or
malignant tumours in these mice, its timing and degree must have been similar for
each cage, which is unlikely.
Final application
ofcrotonoil
limeinweeks
FIG. 10.-Development of papillomata during croton oil treatment in mice housed in two
different cages. The mice ofGroup 1 were housed, throughout the period ofthe experiment,
in separate cages, each ofwhich originally contained 10 mice. The mean number ofpapillo-
mata per surviving mouse for each cage is plotted against time. Numbers of survivors are
shown in brackets.
EXPLANATION OF PLATES
FIG. 1.-A large, pedunculated papilloma and a clearly defined patch ofirregularly thickened
skin on a mouse 65 weeks after the beginning of weekly applications of croton oil (Group 1).
FIG. 2.-Papillomata on the back of a mouse 52 weeks after the beginning of weekly applica-
tions of croton oil (Group 1).
FIG. 5.-Two carcinomata on the back ofa mouse treated with 72 weeklv applications ofcroton
oil, 12 weeks after the end of treatment (Group 1).
FIG. 6-9.-Photomicrographs of the two carcinomata shown in Fig. 5.
One of these tumours (Fig. 6 and 7) was a well-differentiated squamous-cell carcinoma which
-had penetrated the panniculus camosus at one point. This point is indicated by an arrow in Fig. 6,
and may be seen under higher magnification in Fig. 7.
The second tumour (Fig. 8 and 9) consisted mostly of undifferentiated pleomorphic cells, though
parts showed more differentiation. Penetration of the panniculus camosus, which occurred over a
-wide area, is illustrated in Fig. 9, a higher power view ofthe spot indicated by an arrow in Fig. 8.
[Staining: Haematoxylin and Eosin-Biebrich-scarlet (Salaman and Gwynn, 1951). Magni-
fication: Fig. 6 and 8, x 35; Fig. 7 and 9, x 288.]
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(c) The incidence ofpulmonary adenomata
In a previous communication (Roe and Salaman, 1955; p. 196) a preliminary
report was made concerning the incidence of lung tumours in the group of mice
which form Group 1 of the present paper. It was stated there that of the 15 mice
which had died to date, "10 bore no adenomata and the remaining 5 bore 20, 3,
2, 1 and 1, respectively ". These figures were based upon the naked-eye examina-
tion of lungs at post-mortem, which is very seldom misleading. In this case,
however, subsequent histological examination ofthelungs showedthatinthe mouse
stated to have 20lung adenomatathesewere infact massesoflymphoid cells. Histo-
logical examination confirmed naked-eye diagnosis in the other four mice.
Post-mortem examination of the remaining 5 mice of this group revealed one
adenoma only.
The incidence of lung adenomata in the 17 mice of Group 2 which were killed
3 weeks after the end ofcroton oil treatment was as follows: 6 mice bore a total of
8 adenomata of 1 mm. diameter or larger.
This incidence oflung tumours in mice after 18 weekly treatments with croton
oil (Group 2), or after a much longer course (Group 1), is well within the normal
incidence for untreated mice of the same strain (unpublished data).
CONCLUSIONS
Eighteen weekly applications of croton oil to the backs of mice regularly
induced the formation ofa few papillomata. Almost all these tumours disappeared
when the mice were thereafter kept without treatment. When croton oil treatment
was prolonged to 72 weeks the incidence of papillomata steadily increased, and
carcinomata eventually appeared. The incidence of pulmonary tumours was not
increased by application ofcroton oil to the skin. These results will be discussed in
another communication (Salaman and Roe, 1956).
SUMMARY
1. Six groups of 20 mice have been given from 18 to 72 weekly applications of
croton oil dissoved in acetone to the skin of the back.
2. Papillomata were seen in 5 out ofthe six groups after 18 weekly applications
of croton oil. When no further treatment was given almost all these tumours
disappeared. When weekly treatment was continued the incidence ofpapillomata
steadily increased.
3. Two different batches of croton oil were used; 3 of the groups were treated
with each batch. Tumour production by the two batches was similar.
4. Seven histologically proven malignant tumours were seen amongst 20 mice
after 55 to 72 weekly applications of croton oil.
5. The incidence oflung adenomata was not increased by application of croton
oil.
6. Discussion of these results is deferred to another communication (Salaman
and Roe, 1956).
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